Press release
Global Depression Treatment Market Share 2021: Global Trends, Key Players, Industry Analysis Report to 2027
The global depression treatment Market is anticipated to grow at a CAGR of 4.1% during the forecast period (2020-2027). The increasing number of FDA approvals for antidepressants along with the expansion in pipeline products by key market players are certain factors driving the growth of the depression treatment industry.To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/depression-treatment-market
In February 2021, Zydus Cadila has received US FDA approval for Nortriptyline Hydrochloride Capsules USP. The capsules come up in the strength of 10 mg, 25 mg, 50 mg, and 75 mg. Nortriptyline Hydrochloride Capsules USP is majorly used for the treatment of depression.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/depression-treatment-market
Moreover, in July 2020, VistaGen Therapeutics, a US-based biopharmaceutical company had received US FDA approval for PH94B under Phase 3 development to treat acute anxiety and mental illness in adult patients with a social anxiety disorder (SAD). PH94B is an investigational rapid-onset neurosteroid nasal spray majorly used for the treatment of social anxiety disorder.
Furthermore, in March 2019, Johnson & Johnson’s ketamine-derived nasal spray Spravato for treatment-resistant depression has been approved by the FDA. The Spravato CIII Nasal Spray is used for the treatment of depressive disorder in adults with a high risk of major depressive disorder (MDD). Thus, these approvals by the FDA for antidepressant drugs produced by major key players, the depression treatment market is expected to witness significant growth during the forecast period.
Market Segmentation
By Drug Type
• Selective Serotonin Reuptake Inhibitors
• Tricyclic Antidepressants
• Serotonin-Norepinephrine Reuptake Inhibitors
• Monoamine Oxidase Inhibitors
• Others
Regional Analysis
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of the Asia-Pacific
Rest of the World
Company Profiles
• Alkermes Plc
• Allergen Plc
• AstraZeneca plc
• Bausch Health Companies, Inc.
• Eli Lilly and Co.
• F. Hoffmann-La Roche AG
• Garmin Ltd.
• GlaxoSmithKline plc
• H. Lundbeck A/S
• Johnson & Johnson Services, Inc.
• Lief Therapeutics
• Lupin Ltd.
• MagVenture, Inc.
• Mylan N.V.
• Novartis AG
• Otsuka Pharmaceutical Co., Ltd.
• Pfizer, Inc.
• Sanofi SA
• Takeda Pharmaceutical Co. Ltd.
• Teva Pharmaceutical Industries Ltd.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/depression-treatment-market
Media Contact:
Company name: Orion Market Research
Contact person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Depression Treatment Market Share 2021: Global Trends, Key Players, Industry Analysis Report to 2027 here
News-ID: 2281605 • Views: …
More Releases from Orion Market Research
Medication Management System Market Size Analysis, Competitive Insights, Leading …
Medication management market at approximately USD 3.0 billion in 2023, projected to reach USD 8.2 billion by 2033, yielding a compound annual growth rate (CAGR) of about 10.6% from 2024 to 2033.
Medication Management System Market Overview
The Medication Management System Market is witnessing significant expansion, driven by the increasing need to reduce medication errors, streamline pharmacy workflows, and enhance patient safety. Adoption of digital health solutions-such as electronic health records (EHR),…
Generative AI in Fintech Market Size Analysis, Competitive Insights, Leading Pla …
Generative AI in Fintech market was valued at approximately USD 1.18 billion, and it is projected to reach around USD 25.8 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 36.2% from 2024 to 2033.
Generative AI in Fintech Market Overview
The Generative AI in Fintech market is experiencing explosive growth as financial institutions increasingly adopt AI-powered tools to personalize services, improve fraud detection, streamline compliance, and automate core…
AI-Based Clinical Trial Solutions for Patient Matching Market Comprehensive Rese …
AI Based Clinical Trial Solutions for Patient Matching market was valued at approximately USD 300 million, and it is anticipated to grow to around USD 2.1 billion by 2033, representing a compound annual growth rate (CAGR) of about 22% between 2024 and 2033.
AI-Based Clinical Trial Solutions for Patient Matching Market Overview
The AI Based Clinical Trial Solutions for Patient Matching market is experiencing robust expansion as pharmaceutical companies and CROs increasingly…
SCADA Alarm Management Market Size Future Scope, Demands and Projected Industry …
SCADA Alarm Management Market was valued at approximately USD 532 million, with projections indicating it will reach around USD 1.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 12.1% from 2024 to 2033.
SCADA Alarm Management Market Overview
The SCADA Alarm Management Market is experiencing strong growth as industries such as utilities, oil & gas, manufacturing, and water treatment increasingly prioritize efficient and intelligent alarm handling. These systems…
More Releases for FDA
DreaMed receives 5th FDA Clearance
TEL AVIV, Israel: DreaMed Diabetes LTD. ("DreaMed" or the "Company"), developer of the endo.digital Clinical Decision Support System announced today that it has received its 5th U.S Food and Drug Administration (FDA) clearance that expands the scope of AI enhanced treatment recommendations to patients on fixed meal insulin regimens. endo.digital is the first decision support system that has been cleared to assist healthcare providers in the management of diabetes…
FDA Compliant Blood Storage and Preservation
Accsense Monitoring System Automates Data Archive and Alarming
CAS DataLoggers provided the temperature alarming and monitoring system to a hospital blood bank looking to replace their old paper chart recorders as they became unreliable and spare parts were harder to find. For proper blood storage and preservation, the lab’s medical units needed to maintain storage temperatures between 2°C to 6°C (36°F to 43°F), given the perishability of blood components. The facility…
FDA grants orphan drug status to Vicore
US Food and Drug Administration has awarded Vicore Pharmaceuticals with orphan Drug designation for the treatment of Idiopathic Pulmonary Fibrosis (IPF). FDA’s Orphan Drug Designation program provides certain incentives for companies developing therapeutics to treat rare diseases or conditions, defined as those affecting less than 200,000 individuals in the U.S. A drug candidate and its sponsor must meet several key criteria in order to qualify for, and obtain, orphan drug…
New FDA Design Control Training Courses
Salt Lake City, Utah - February 23 2017 - Procenius Consulting is a medical device consulting firm specializing solely in medical device design controls regulation (21 CFR 820.30).
Announcing New Design Control Training Courses
Procenius Consulting has just launched two new training courses covering basic and advanced topics of medical device design control regulation. These courses focus on compliance, practical implementation and industry best practices techniques for developing or improving a…
fda online training
GRC Training Solutions provides end-to-end FDA compliance solutions for those companies who want to maximize security, minimize operational costs, improve staff productivity and stay on top of all their compliance documentation.
GRC Training Solutions boasts a team of experts and specialists who have a proven track record in working with the biotechnology, medical device, diagnostic and pharmaceutical fields. Our team will work with you closely and develop solutions that meet…
FDA online training
Description:
Device firms, establishments or facilities that are involved in the production and distribution of medical devices intended for use in the U.S are required to register annually. Most establishments that are required to register with the FDA are also required to list the devices that are made there and the activities that are performed on those devices. Initially, FDA issued a 28-page Proposed Rule that would amend its regulations regarding…
